Vitamin d, calcium and spike protein – a trilogy of trouble?

Clinical observations linking spike protein exposure, mast cell activation and Vitamin D receptor dysfunction — with patterns identified through QCS scanning in A+ and O+ blood type clients.

J
Jared Murray Author
September 2024 0 min read

The Clinical Pattern

In my recent QCS scans, I have noticed a puzzling pattern of hypervitaminosis D, increased calcium, parathyroid hormone and associated influences. This leads me to wonder — do we need to re-examine the role of Vitamin D, especially with direct or indirect exposure to the COVID spike protein?

These cases fit into two predominant categories. Those with A+ blood type had hypervitaminosis D and typically hypercalcemia. O+ blood type clients typically presented with just hypercalcemia. In my observations, 99% of the time clients fit into these two groups.

Mast Cells & COVID Hyperinflammation

In the early days of COVID, much discussion centred on Vitamin D deficiency creating increased morbidity and mortality. The ACE-2 receptor was thought to be influenced in part by Vitamin D cell and nuclear receptors on macrophages — leading many to mega-dose on Vitamin D. But that isn’t the whole story.

In November 2020, a group of doctors and mast cell researchers noted: “Much of Covid-19’s hyperinflammation is related to inflammation which mast cell [MC] activation can drive. Drugs with activity against MCs or their mediators have preliminarily been observed to be helpful in Covid-19 patients.” PMID: 32920235

QCS scan data showing Vitamin D and calcium dysregulation patterns

QCS scan data illustrating the Vitamin D and calcium patterns observed across client populations.

Key finding: None of the authors’ treated MCAS patients with Covid-19 suffered severe infection or mortality. Hyperinflammatory cytokine storms in severely symptomatic patients may be due to an atypical response to SARS-CoV-2 by dysfunctional mast cells of MCAS — not a normal response by normal mast cells.

Mast cells discharge an inflammatory soup of histamine, leukotrienes, prostaglandins and cytokines when triggered. Present in most tissues — including the lung, gut and brain (as microglial cells) — a dysregulated degranulation of mast cells results in allergy or hyper-inflammation.

Spike Protein & Mast Cell Degranulation

In December 2021, Wu et al. published “SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury.” PMID: 34921131

Spike protein binding to ACE2 receptor on mast cells triggering degranulation

The spike protein binds to the ACE2 receptor on mast cells, triggering degranulation — relevant to both COVID infection and mRNA vaccine exposure.

Critical insight: Researchers could reproduce the mast cell degranulation effects using just the spike protein binding to the ACE2 receptor — making findings relevant not only to COVID infection but also to mRNA vaccines, which instruct the body to produce the spike protein for an unknown duration.

The VDR Hypothesis — Why Vitamin D Looks Elevated

My belief is that the Vitamin D Receptor (VDR) function may be overwhelmed by dysregulated spike protein responses, causing increased serum Vitamin D levels — and in QCS scanning, causing calcium build-up in the body, also known as granulomatous disease. PMID: 33864942

In more than half of these cases, clients were NOT consuming Vitamin D despite elevated serum levels. Analysis indicated the client did need Vitamin D — however could not absorb it. This is a fundamental departure from conventional understanding of Vitamin D deficiency in the context of COVID infection.

A 2017 study found that mast cells activate spontaneously in a Vitamin D-deficient environment, and Vitamin D levels are inversely correlated with COVID severity. PMID: 27998003 Maintaining adequate plasma Vitamin D depends not just on diet and sun exposure, but on reduction in pollutant, pesticide and glyphosate exposure and a healthy microbiome.

The Gut–Mast Cell–Vitamin D Triangle

Inflammatory endotoxin LPS, produced by certain gut bacteria, drives chronic inflammation via endotoxemia. Chronic inflammation depletes Vitamin D. LPS upregulates Vitamin D-metabolising enzymes (CYP27B1 and CYP24A1) in white blood cells, accelerating Vitamin D degradation.

Mast cell stabilisation requires maintaining a healthy gut barrier to prevent LPS leakage into the bloodstream. Is it possible that one answer to hypervitaminosis D lies in leaky gut — made worse by dysregulated mast cells that themselves contribute to gut barrier dysfunction, potentially fuelling their own destabilisation?

Additional mast cell destabilisers include endocrine-disrupting herbicides, environmental toxicities, power-frequency EMFs and psychological stress via stress hormones and neurochemicals.

Clinical Observations by Blood Type

QCS scan patterns showing calcium dysregulation in A+ and O+ blood types

Distinct patterns observed in QCS scanning: hypervitaminosis D predominantly in A+ clients, hypercalcemia in both A+ and O+ populations.

Exposure to the spike protein appears to cause dysregulation of both Vitamin D and calcium in A+ clients. In O+ clients, Vitamin D dysregulation was not apparent — however, hypercalcemia was consistently present. In both cases, hypercalcemia symptoms predominated: nausea, GI issues, fatigue despite inability to sleep, restless legs, achy joints, vision issues, cloudy thinking and neurological changes.

Clinical Approach & Alive Innovations Support

Healing from long-COVID, COVID vaccine injury, or preparing to handle COVID exposure uneventfully should include mast cell care and microbiome support to regulate Vitamin D absorption and calcium metabolism.

In my lifetime I have rarely seen Vitamin D toxicity — especially in those not supplementing. Seeing clients in their 30s–50s with calcium issues where thyroid and parathyroid function is clinically normal is extraordinary. The spike protein appears pervasive in these observations, clearly linked with these conditions — creating a Trilogy of Trouble.

Disclaimer: The information provided is for educational purposes only and should not be construed as medical advice. Always consult a healthcare professional before starting any new treatment regimen. The efficacy and safety of supplements can vary based on individual health profiles. These statements have not been evaluated by the FDA. Products mentioned are not intended to diagnose, treat, cure or prevent any disease.